$73.60
0.050.07%
Pre-Market: 4:34 PM EDT
Comments
Loading...
DexCom Stock Guidance | NASDAQ:DXCM | Benzinga
DexCom issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/07/2025 | DXCM | DexCom | FY | 2025 | — | — | — | $4.60B | $4.60B | $4.60B | Get Alert |
| 02/13/2025 | DXCM | DexCom | FY | 2025 | — | — | — | $4.60B | $4.60B | $4.61B | Get Alert |
| 01/13/2025 | DXCM | DexCom | Q4 | 2024 | — | — | — | $1.11B | — | $1.10B | Get Alert |
| 01/13/2025 | DXCM | DexCom | FY | 2024 | — | — | — | $4.03B | $4.03B | $4.02B | Get Alert |
| 01/13/2025 | DXCM | DexCom | FY | 2025 | — | — | — | $4.60B | $4.60B | $4.60B | Get Alert |
| 10/24/2024 | DXCM | DexCom | FY | 2024 | — | — | — | $4.00B | $4.05B | $4.01B | Get Alert |
| 07/25/2024 | DXCM | DexCom | Q3 | 2024 | — | — | — | $975.00M | $1.00B | $1.15B | Get Alert |
| 07/25/2024 | DXCM | DexCom | FY | 2024 | — | — | — | $4.00B | $4.05B | $4.33B | Get Alert |
| 04/25/2024 | DXCM | DexCom | FY | 2024 | — | — | — | $4.20B | $4.35B | $4.33B | Get Alert |
| 02/08/2024 | DXCM | DexCom | FY | 2024 | — | — | — | $4.15B | $4.35B | $4.33B | Get Alert |
| 01/08/2024 | DXCM | DexCom | FY | 2024 | — | — | — | $4.15B | $4.35B | $4.32B | Get Alert |
| 01/08/2024 | DXCM | DexCom | FY | 2023 | — | — | — | $3.62B | $3.62B | $3.59B | Get Alert |
| 01/08/2024 | DXCM | DexCom | Q4 | 2023 | — | — | — | $1.03B | — | $1.01B | Get Alert |
| 10/26/2023 | DXCM | DexCom | FY | 2023 | — | — | — | $3.58B | $3.60B | $3.54B | Get Alert |
| 09/06/2023 | DXCM | DexCom | FY | 2023 | — | — | — | $3.50B | $3.55B | $3.54B | Get Alert |
| 07/27/2023 | DXCM | DexCom | FY | 2023 | — | — | — | $3.50B | $3.55B | $3.50B | Get Alert |
| 06/26/2023 | DXCM | DexCom | FY | 2025 | — | — | — | $4.60B | $5.10B | — | Get Alert |
| 04/27/2023 | DXCM | DexCom | FY | 2023 | — | — | — | $3.40B | $3.52B | $3.47B | Get Alert |
| 02/09/2023 | DXCM | DexCom | FY | 2023 | — | — | — | $3.35B | $3.49B | $3.47B | Get Alert |
| 01/09/2023 | DXCM | DexCom | FY | 2023 | — | — | — | $3.35B | $3.49B | $3.47B | Get Alert |
| 01/09/2023 | DXCM | DexCom | FY | 2022 | — | — | — | $2.91B | $2.91B | $2.90B | Get Alert |
| 01/09/2023 | DXCM | DexCom | Q4 | 2022 | — | — | — | $815.00M | — | $807.65M | Get Alert |
| 10/27/2022 | DXCM | DexCom | FY | 2022 | — | — | — | $2.88B | $2.91B | $2.89B | Get Alert |
| 07/28/2022 | DXCM | DexCom | FY | 2022 | — | — | — | $2.86B | $2.91B | $2.92B | Get Alert |
| 04/28/2022 | DXCM | DexCom | FY | 2022 | — | — | — | $2.82B | $2.94B | $2.92B | Get Alert |
| 02/10/2022 | DXCM | DexCom | FY | 2022 | — | — | — | $2.82B | $2.94B | $2.96B | Get Alert |
| 01/10/2022 | DXCM | DexCom | Q4 | 2021 | — | — | — | $698.00M | $698.00M | $696.47M | Get Alert |
| 01/10/2022 | DXCM | DexCom | FY | 2021 | — | — | — | $2.45B | $2.45B | $2.45B | Get Alert |
| 10/28/2021 | DXCM | DexCom | FY | 2021 | — | — | — | $2.42B | $2.45B | $2.40B | Get Alert |
| 07/29/2021 | DXCM | DexCom | FY | 2021 | — | — | — | $2.35B | $2.40B | $2.34B | Get Alert |
| 04/29/2021 | DXCM | DexCom | FY | 2021 | — | — | — | $2.26B | $2.36B | $2.32B | Get Alert |
| 02/11/2021 | DXCM | DexCom | FY | 2021 | — | — | — | $2.21B | $2.31B | $2.33B | Get Alert |
| 01/11/2021 | DXCM | DexCom | Q4 | 2020 | — | — | — | $567.00M | — | $550.73M | Get Alert |
| 01/11/2021 | DXCM | DexCom | FY | 2020 | — | — | — | $1.93B | — | $1.91B | Get Alert |
| 01/11/2021 | DXCM | DexCom | FY | 2021 | — | — | — | $2.21B | $2.31B | $2.33B | Get Alert |
| 10/27/2020 | DXCM | DexCom | FY | 2020 | — | — | — | $1.90B | $1.90B | $1.87B | Get Alert |
| 10/26/2020 | DXCM | DexCom | Q3 | 2020 | — | — | — | $500.90M | $500.90M | $476.75M | Get Alert |
| 07/28/2020 | DXCM | DexCom | FY | 2020 | — | — | — | $1.85B | $1.85B | $1.80B | Get Alert |
FAQ
What is the most recent guidance for DexCom (DXCM)?
There have been no specific sales or earnings guidance reported for DexCom in recent months.
Browse guidance and forecast on all stocks.